Collaborative nurse-led self-management support for primary care patients with anxiety, depressive or somatic symptoms: Cluster-randomised controlled trial (findings of the SMADS study). (November 2016)

• Record Type: Journal Article
• Authors: Zimmermann, Thomas; Puschmann, Egina; van den Bussche, Hendrik; Wiese, Birgitt; Ernst, Annette; Porzelt, Sarah; Daubmann, Anne; Scherer, Martin
• Is Part Of: International journal of nursing studies. Volume 63(2016)
• Page Start: 101
• Page End: 111
• Publication Date: 2016-11
• Subjects: Nurse-led intervention -- Self-management support -- Psychosomatic symptoms -- Primary care -- Cluster-randomised -- Controlled trial -- Self-efficacy -- General practitioner -- Case management -- Psychological disorders -- Collaborative care; Nursing -- Periodicals; Nursing -- Periodicals; Soins infirmiers -- Périodiques; Nursing; Periodicals; 610.73
• DOI: 10.1016/j.ijnurstu.2016.08.007
• Languages: English
• ISSNs: 0020-7489

Abstract

Abstract: Background: Collaborative, nurse-led care is a well-established model of ambulatory care in many healthcare systems. Nurses play a key role in managing patients' conditions as well as in enhancing symptom- and self-management skills. Objective: The SMADS trial evaluated the effectiveness of a primary care-based, nurse-led, complex intervention to promote self-management in patients with anxiety, depressive or somatic symptoms. Change in self-efficacy 12 months post baseline was used as the primary outcome. Design: The SMADS trial set up a two-arm, cluster randomised controlled trial in the city of Hamburg, a large metropolitan area in the North West of Germany. Setting: We randomly allocated participating primary care practices to either the intervention group (IG), implementing a nurse-led collaborative care model, or to the control group (CG), where patients with the above psychosomatic symptoms received routine treatment. Participants: Patients from 18 to 65 years of age, regularly consulting a participating primary care practice, scoring ≥ 5 on the anxiety, depressive or somatic symptom scales of the Patient Health Questionnaire (PHQ-D), German version. Methods: A mixed model regression approach was used to analyse the outcome data. Analyses were based on the intention-to-treat population: All enrolled patients were analysed at their follow-up. Additionally, we reported results as effect sizes. The robustness of the results was investigated by performing an observed cases analysis. Results: 325 participants (IG N = 134, CG N = 191) from ten practices in each study arm consented to take part and completed a baseline assessment. The mean group difference (ITT-LOCF, IG vs. CG) in self-efficacy at the post baseline follow-up (median 406 days) was 1.65 points (95% CI 0.50–2.8) in favour of IG (p = 0.004). This amounts to a small Cohen's d effect size of 0.33. An observed cases analysis (168 participants, IG = 56, CG = 105) resulted in a mean difference of 3.13 (95% CI 1.07–5.18, p = 0.003) between the groups, amounting to a moderate effect size of d = 0.51. Conclusion: A complex, nurse-led intervention, implemented as a collaborative care model, increased perceived self-efficacy in patients with symptoms of anxiety, depression or somatisation compare to control patients. For the first time in the German healthcare system, the SMADS trial validated the belief that a nurse can successfully complement the work of a general practitioner – particularly in supporting self-management of patients with psychosomatic symptoms and their psychosocial needs.